Crossmark

Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome

Crossref DOI link: https://doi.org/10.1186/s13613-014-0022-z

Published Print: 2014

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Liu, Kathleen D

Wilson, Jennifer G

Zhuo, Hanjing

Caballero, Lizette

McMillan, Melanie L

Fang, Xiaohui

Cosgrove, Katherine

Calfee, Carolyn S

Lee, Jae-Woo

Kangelaris, Kirsten N

Gotts, Jeffrey E

Rogers, Angela J

Levitt, Joseph E

Wiener-Kronish, Jeanine P

Delucchi, Kevin L

Leavitt, Andrew D

McKenna, David H

Thompson, B Taylor

Matthay, Michael A
License Information

Text and Data Mining valid from 2014-01-01

Text and Data Mining valid from 2014-01-01

Version of Record valid from 2025-11-19
More Information

This article is maintained by: Elsevier

Article Title: Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome

Journal Title: Annals of Intensive Care

CrossRef DOI link to publisher maintained version: https://doi.org/10.1186/s13613-014-0022-z

Content Type: article

Copyright: Copyright © 2014 Liu et al.; licensee Springer 2014. Published by Elsevier Masson SAS

Document is current

Any future updates will be listed below